Delta-Fly Pharma, Inc. Logo

Delta-Fly Pharma, Inc.

Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.

4598 | T

Overview

Corporate Details

ISIN(s):
JP3549370009
LEI:
Country:
Japan
Address:
徳島市川内町宮島錦野37番地の5
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer agents. The company utilizes its proprietary "Module Drug Development" concept to create innovative and "gentle" cancer treatments designed to have reduced side effects and be available at a reasonable price. Its development pipeline focuses on small molecule and RNA therapeutics for various cancers, including Acute Myeloid Leukemia. Delta-Fly Pharma's mission is to develop medicines that benefit cancer patients and society through its unique drug discovery approach.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:39
Interim Report
確認書
Japanese 8.9 KB
2025-11-14 07:35
Interim Report
半期報告書-第16期(2025/04/01-2026/03/31)
Japanese 206.9 KB
2025-06-27 08:44
Post-Annual General Meeting Information
臨時報告書
Japanese 24.4 KB
2025-06-27 08:39
Governance Information
内部統制報告書-第15期(2024/04/01-2025/03/31)
Japanese 23.0 KB
2025-06-27 08:34
Registration Form
確認書
Japanese 8.8 KB
2025-06-27 08:30
Registration Form
有価証券報告書-第15期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-04-14 08:30
Prospectus
有価証券届出書(組込方式)
Japanese 289.0 KB
2024-11-14 07:39
Interim Report
確認書
Japanese 8.9 KB
2024-11-14 07:36
Interim Report
半期報告書-第15期(2024/04/01-2025/03/31)
Japanese 180.2 KB
2024-10-07 08:00
Major Shareholding Notification
臨時報告書
Japanese 22.6 KB
2024-09-20 08:00
Registration Form
有価証券届出書(組込方式)
Japanese 326.2 KB
2024-09-11 08:00
Major Shareholding Notification
臨時報告書
Japanese 22.8 KB
2024-06-28 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 23.5 KB
2024-06-28 08:28
Registration Form
確認書
Japanese 8.8 KB
2024-06-28 08:25
Governance Information
内部統制報告書-第14期(2023/04/01-2024/03/31)
Japanese 22.6 KB

Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Delta-Fly Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.